-DNA A nursery in a small Tamil Nadu town is enabling Irula women, once a forest-dwelling people, to gradually join the mainstream, reports Marisha Karwa Where do you go when you have no place to call home? What do you do when your means of livelihood has been declared illegal? And how do you live a life that is alien to the ways and norms of what has been passed to...

-The Hindu Though the Union Environment Ministry acknowledges its damage, Uttarakhand's hydroelectric project-driven development agenda remains unchanged Chaaen, a village atop a hill in the picturesque Alaknanda Valley, is infamous for getting a hydroelectric project into trouble. I first visited the village last year while covering the worst flood disaster Uttarakhand had witnessed. On June 26, 2013, as I stood at Narendra Singh's verandah in Chaaen, I noticed how the walls had developed...

-The Hindu Business Line   The closure of three urea producing plants in south India has led to a sharp spike in imports and subsidies In April 2014, the UPA government in its last days, cut off the lifeline of three urea plants. It gave a final push to a ten-year-old trend of replacing domestic urea production with imports. The government-owned Madras Fertilisers, and the private sector units SPIC and MCF closed down...

-Livemint The development economist on the Modi government's initiatives and his stand on them, and MGNREGS The Narendra Modi-led government should consider replacing inefficient subsidies with a basic monthly income for all citizens, says Pranab Bardhan , emeritus professor of economics at the University of California at Berkeley. Bardhan, who recently sparred with economists Jagdish Bhagwati and Arvind Panagariya in a debate over the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS),...

-The Hindu In a significant development for the pharmaceutical industry, the Supreme Court has rejected multinational Bayer's appeal to block production and sales of the low cost version of its kidney cancer drug, sorafenib tosylate (branded as Nexavar), by Natco Pharmaceuticals. Hyderabad-based Natco was granted the first and to date only compulsory licence (CL) by the government in 2012 to make and sell a patented drug at a fraction of the...